Nick Khan

Director Nick Khan sold 9,589 shares for $1,990,265.72 on 2026-06-12 per pre-arranged 10b5-1 plan

Nick Khan, a TKO director, executed 15 separate sales totaling 9,589 shares for $1,990,265.72, reducing his holdings from 91,100 shares to 81,511 shares. The transaction was conducted under a pre-arranged 10b5-1 trading plan adopted on 2026-03-13, meaning it was scheduled and non-discretionary. The sales occurred across a range of prices from $199.37 to $216.06, with a blended average of $207.56, compared to a current stock price of $200.03. At the same ticker, Khan's prior five sales showed mixed 30-day outcomes: three posted positive returns (+6.2%, +7.0%, +6.6%) while two posted negative returns (-4.1%, -5.1%). The company reported strong fundamentals with annual revenue growth of +68.8% and net income of $89,351,000.00, though a notably elevated P/E of 82.66 reflects the market's valuation assumptions.

Director Khan Nick sold ~9,500 shares of TKO worth $1.77M, continuing a pattern of consistent selling.

Khan Nick, a TKO director, sold approximately 9,500 shares across three transactions on the same day for a combined value of $1.77 million, reducing his holdings by roughly 10 percent. This marks his 21st recorded transaction in the company, and notably, all 20 prior trades have been sales—a pattern of consistent, systematic selling rather than buying or holding conviction. His previous sales-timed well historically, with the stock typically declining after his prior exits, suggesting he has demonstrated ability to identify downturns. However, the current context complicates the signal: the stock is trading well below its year's high, has declined over the past month and quarter, and yet the company remains solidly profitable with strong recent revenue growth. Khan Nick is selling into weakness rather than strength, which could reflect either prudent risk management or a lack of confidence that the stock will recover from its recent pullback despite the company's solid fundamentals.

TKO director Nick Khan sold 9,518 shares for $1,890,225.02 on 2026-04-06; stock now at $192.96, down 14.2% from 52-week high.

Khan sold 9,518 shares across five separate transactions at an average price of $198.59, reducing his holding from 110,136 to 100,618 shares. The current price of $192.96 is now below the transaction prices, representing a -14.2% decline from the 52-week high of $224.96. His prior sales at TKO show a consistent pattern: four recent sells on 2026-03-03 all posted negative 30-day returns ranging from -8.2% to -7.0%, and an earlier January sale saw a +4.5% return. Across his broader open-market history, Khan's sells have posted an average 90-day return of +5.9% with only 33.33% well-timed outcomes, meaning his selling decisions have not reliably preceded declines. The company's P/E of 79.74 and accelerating fundamentals (68.8% annual revenue growth) suggest a high-valuation growth story, but recent price weakness and Khan's repeated dispositions suggest either portfolio rebalancing at elevated valuations or caution about forward momentum.

Director Khan Nick sold 9,518 shares at blended avg $220.29 for $2.1M at TKO on 2026-03-03.

Khan Nick, a director at TKO Group Holdings, executed 4 separate sales totaling 9,518 shares for $2,096,737.27 on 2026-03-03, reducing his holdings from 119.6K to 110.0K shares (-8.0%). The sales occurred across a narrow price band ($219.03–$220.81), with a blended average of $220.29, near the stock's 52-week high of $224.96. Notably, the stock is currently trading at $216.23, below the transaction prices. His cross-ticker track record shows 20 prior sells with an average 90-day return of +8.9% and a well-timed rate of 0.00%, indicating his prior sells have not preceded declines; his same-ticker history at TKO shows 5 recent sells on 2026-01-22 with positive 30-day returns (3.0%–4.8%), all within a month ago. The company's fundamentals show strong revenue growth of +68.8% year-over-year, though the elevated P/E of 89.35 reflects significant valuation premia.

Director Khan Nick sold 9,518 shares at $201.31 average price on 2026-01-22 for $1.9M, reducing stake by 7.4% to 119.6K shares.

Khan Nick executed 6 separate sales totaling 9,518 shares for $1,916,048.14 on 2026-01-22, with transaction prices ranging from $199.33 to $204.91. His post-transaction holding of 119.6K shares represents a 7.4% reduction from the prior 129.1K shares. The blended average sale price of $201.31 is positioned near the middle of the 52-week range ($138.96–$217.98) and approximately 1.1% below the current price of $203.50. His cross-ticker track record shows 20 prior sells with a 90-day well-timed rate of 0.00%, indicating that historically his sell decisions have not preceded stock declines; additionally, four other sales at TKO on 2026-01-05 have not yet produced measurable outcomes. The company's fundamentals show revenue of $1,119,914,000.00 with net income of $41,005,000.00 and an exceptional 67.4% annual revenue growth rate, though the P/E ratio of 1695.83 reflects compressed earnings relative to valuation.

Director Khan Nick sold 7,744 shares of TKO at $201.98 on 2026-01-22 for $1.6M, retaining 129.1K shares.

Khan Nick, a Director, liquidated 7,744 shares representing -5.7% vs pre-transaction holdings, leaving him with a substantial position of 129.1K shares post-sale. The sale occurred at $201.98; the stock has since declined to $200.13 (currently -8.2% from its 52-week high of $217.98 and down 7.2% over 30 days). Across his cross-ticker track record, this insider's 20 prior sells averaged a positive 30-day return of +1.8%, but a well-timed rate of 0.00%, indicating his prior sales have generally not preceded subsequent declines. At TKO specifically, this is the latest in a sequence of five sales on 2026-01-22, all with outcomes not yet measurable. The company shows strong growth (revenue +67.4% year-over-year) and substantial scale ($1.1B quarterly revenue), though the P/E of 1667.75 reflects minimal net income relative to market valuation.

Director Khan Nick sold 37,425 shares at blended $204.01 on 2026-01-05, reducing holdings by -23.3% to 122,867 shares for $7.6M.

Khan Nick executed 4 separate sales totaling 37,425 shares for $7,635,022.16 on 2026-01-05, with transaction prices ranging from $203.38 to $205.09, substantially above the current price of $203.65. The sale reduced his holdings by -23.3%, representing a material reduction in his stake. His cross-ticker track record shows 20 prior sells with a 90-day well-timed rate of 0.00%, while his 5 prior TKO trades all occurred in November and early December 2025 with positive 30-day returns (3.0% to 6.5%). Against TKO's fundamentals of Revenue $1,119,914,000.00 and +67.4% annual growth, but a notably elevated P/E of 1697.08 driven by modest Net income of $41,005,000.00, this large director liquidation warrants attention to whether it reflects valuation concerns or portfolio-level rebalancing.

Director Khan Nick sold 9,519 shares at $194.35–$196.11 for $1,857,735.13 on 2025-12-03; retains 108,984 shares.

Khan Nick executed 3 separate sales totaling 9,519 shares for $1,857,735.13 at a blended average price of $195.16, reducing his stake by 8.0% to 108,984 shares. The current price of $202.22 is 3.5% above the blended transaction price, indicating the director sold into modest near-term strength (stock is up 8.0% over 30 days and 4.2% over 90 days). Across his prior cross-ticker sell history, 20 prior sells averaged a 11.1% gain over 90 days with a well-timed rate of 0.00%, reflecting a pattern of selling before flat-to-positive price movements. At this specific ticker, recent sells on 2025-11-03 showed 30-day returns between 3.0% and 4.5%, though 90-day outcomes remain unavailable. The company's fundamentals show strong revenue growth of 67.4% year-over-year ($1.1B latest quarter), though the P/E of 1685.17 reflects minimal current earnings ($41.0M net income) relative to valuation.

Director Khan Nick sells 9,519 shares ($1.8M) at blended $188.26; retains 118.5K shares post-trade at TKO.

Director Khan Nick executed four separate sales on 2025-11-03 totaling 9,519 shares for $1,792,064.55, reducing his position from 128,022 to 118,503 shares (-7.4%). The sales prices ranged from $186.49 to $189.25, near the current price of $187.24 and below the 52-week high of $205.33. His prior five trades at TKO (three sells on 2025-10-03, two on 2025-09-03) produced mixed 30-day returns ranging from -5.3% to +6.1%, with no 90-day outcomes yet measurable to assess timing accuracy. The stock has fallen 5.5% over 30 days and is down 8.8% from its 52-week peak, trading in a context of strong fundamentals: annual revenue growth of +67.4%, though a P/E ratio of 1560.33 reflects near-zero profitability relative to market cap. This sale represents a partial position reduction at elevated valuations, with no FLAGS indicating a pre-planned 10b5-1 program.

Director Khan Nick sold 9,519 shares at blended $197.82 for $1.9M on 2025-10-03; 128.0K shares remain.

Khan Nick, a director at TKO Group Holdings, executed 3 separate sales totaling 9,519 shares for $1,883,021.11 on 2025-10-03, leaving 128,022 shares post-transaction—a reduction of 6.9% of his pre-transaction holdings. The stock was trading at $197.96 at filing, near its blended sale price of $197.82 and 3.6% below its 52-week high of $205.33. Notably, Khan's prior trades at TKO (5 documented sales from July and September 2025) have each shown positive 30-day returns (ranging from +4.5% to +9.8%), suggesting prior sales occurred before near-term appreciation rather than declines. His cross-ticker track record shows an average 90-day return of +16.8% following sells, but with a 0.00% well-timed rate, indicating those prior sells were generally followed by further stock gains—opposite of well-timed selling. The company reports strong fundamentals (revenue $1.3B, annual growth +67.4%, net income $98.4M), though the P/E of 1649.67 is notably elevated, reflecting significant market valuation relative to current earnings power. This sale, consistent with his recent pattern, occurs in a period of stock strength and elevated valuation metrics.